Total planned funding: $331,831,994
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $64,298,944 |
| South Africa | $43,238,992 |
| Zambia | $37,674,677 |
| Asia Regional Program | $35,475,616 |
| Mozambique | $24,015,344 |
| Vietnam | $14,318,908 |
| West Africa Region | $13,460,980 |
| Burundi | $10,981,532 |
| Zimbabwe | $9,054,888 |
| Haiti | $8,675,317 |
| Dominican Republic | $7,551,779 |
| Ghana | $6,982,500 |
| enumerations.Philippines | $6,341,584 |
| Ethiopia | $5,547,301 |
| Tanzania | $5,230,431 |
| Botswana | $4,686,634 |
| Malawi | $4,200,600 |
| India | $4,050,000 |
| Kenya | $3,936,903 |
| Côte d'Ivoire | $3,546,882 |
| Lesotho | $3,392,229 |
| South Sudan | $2,868,967 |
| Democratic Republic of the Congo | $2,791,215 |
| Rwanda | $2,594,238 |
| Eswatini | $2,280,500 |
| Indonesia | $2,075,000 |
| Namibia | $1,497,275 |
| Western Hemisphere Region | $709,018 |
| Uganda | $353,740 |
| Cambodia | $0 |
Organizational Types
| NGO | $331,831,994 |
Program Areas
| Care | $94,778,374 |
| Prevention | $84,293,471 |
| Treatment | $81,686,314 |
| Testing | $37,304,495 |
| Governance and Systems | $33,769,340 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $69,198,714 |
| HKID: Care: Orphans and Vulnerable Children | $42,747,736 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $40,459,414 |
| HBHC: Care: Adult Care and Support | $38,714,473 |
| HVCT: Testing: HIV Testing and Counseling | $37,304,495 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $16,354,155 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $15,716,582 |
| HVSI: Strategic Information | $11,988,480 |
| OHSS: Health Systems Strengthening | $11,218,736 |
| HLAB: Laboratory Infrastructure | $10,562,124 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $9,049,819 |
| HVTB: Care: TB/HIV | $7,465,189 |
| PDTX: Treatment: Pediatric Treatment | $7,405,486 |
| PDCS: Care: Pediatric Care and Support | $5,850,976 |
| HTXD: Treatment: ARV Drugs | $5,082,114 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,432,001 |
| HMIN: Biomedical Prevention: Injection Safety | $225,100 |
| HMBL: Biomedical Prevention: Blood Safety | $56,400 |